Skip to headlines
clockwire Search
LIVE
Anthropic’s IPO could deliver $156 billion to charity New regional security architecture will also benefit Europe, Pakistani FM tells Euronews Iran’s Bauxite Mine Reopens Amid Water Fears And Questions Over Military Supply Chains Anthropic IPO Sets New Standard: Rice Nelson NCC moves to reset telecom VAS pricing as revenue-sharing disputes persist Fed Tells Regional Staff to Expect Lower Pay Increases in 2027 The surprising reason the U.S. economy is speeding up — and might have more room to run Bank of America banker Stewart Barry to join Allen & Company, sources say Anthropic IPO Backs Up Private Valuations: Schlossman 820 000 removed: Foreign Uber and Bolt drivers affected by Home Affairs’ TRN clean-up Woman nabbed for possession, use of fake P1,000 bills How Aliencell Is Bringing Precision Engineering to Desktop Laser Engraving What makes a premium mattress worth the investment? Victim’s blood found on knife fetish website murder accused sent to friend Evidence leaders at Madlanga Commission seek closed-door testimony from Khumalo
‹ Back to your news

MARKETS

Insmed may be worth $170 to $210 a share in takeover, analyst

Covered by 1 source Earliest report we found

How each outlet tells it

Seeking Alpha (US) · private

Insmed may be worth $170 to $210 a share in takeover, analyst

Read at Seeking Alpha